Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued

American Surgeon

Volumn 80, Issue 4, 2014, Pages 353-360

  Mathur, Abhishek ^a   Ross, Sharona B ^a   Luberice, Kenneth ^a   Kurian, Tony ^a   Vice, Michelle ^a   Toomey, Paul ^a,b   Rosemurgy, Alexander S ^a  

^a FLORIDA HOSPITAL   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FROZEN SECTION; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; SURGERY; SURGICAL MARGIN; SURVIVAL TIME; ADENOCARCINOMA; CANCER STAGING; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FROZEN SECTIONS; HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; REOPERATION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84904316940     PISSN: 00031348     EISSN: 15559823     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 2004;348: 1625-38.
2. Michaud DS. Epidemiology of pancreatic cancer. Minerva Chir 2004;59:99-111.
3. Raut CP, Tseng JF, Sun CC, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 2007;246:52-60.
4. Hernandez JM, Morton CA, Al-Saadi S, et al. The natural history of resected pancreatic cancer without adjuvant chemotherapy. Am Surg 2010;76:480-5.
5. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001;234: 758-68.
6. Hernandez J, Mullinax J, Clark W, et al. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Ann Surg 2009;250:76-80.
7. House MG, Fong Y, Arnaoutakis DJ, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg 2008;12: 270-8.
8. Yeo CJ, Cameron JL, Sohn TA, et al. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 1997;226:248-57.
9. Cameron JL, Pitt HA, Yeo CJ, et al. One hundred and fortyfive consecutive pancreaticoduodenectomies without mortality. Ann Surg 1993;217:430-5.
10. Gnerlich JL, Luka SR, Deshpande AD, et al. Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma. Arch Surg 2012;147:753-60.
11. Zhang Y, Frampton AE, Kyriakides C, et al. Locorecurrence after resection for ductal adenocarcinoma of the pancreas: predictors and implications for adjuvant chemoradiotherapy. J Cancer Res Clin Oncol 2012;138:1063-71.
12. Chang DK, Johns AL, Merrett ND. Margin clearance and outcome in resected pancreatic cancer. J Clin Oncol 2009;27: 2855-62.
13. Kinsella TJ, Seo Y, Willis J, et al. The impact of resection margin status and postoperative CA19-9 levels on survival and patterns of recurrence after postoperative high-dose radiotherapy with 5-FU-based concurrent chemotherapy for resectable pancreatic cancer. Am J Clin Oncol 2008;31:446-53.
14. Schmidt CM, Glant J, Winter JM, et al. Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma. Surgery 2007;142:572-8.
15. Reddy S, Wolfgang CL, Cameron JL, et al. Total pancreatectomy for pancreatic adenocarcinoma: evaluation of morbidity and long-term survival. Ann Surg 2009;250:282-7.
16. Katz MH, Wang H, Fleming JB, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol 2009;16:836-47.
17. Henne-Bruns D, Vogel I, Luttges J, et al. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg 2000;24:595-601.
18. Pedrazzoli S, DiCarlo V, Dionigi R, et al. Standard versus extended lymphadenectomy associated with pancreaticoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: A multicenter, prospective, randomized study. Ann Surg 1998;228: 508-17.
19. Farnell MB, Pearson RK, Sarr MG, et al. A prospective randomized trial comparing standard pancreaticoduodenectomy with pancreaticoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005;138: 618-28.
20. Riall TS, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma-part 3: update on 5-year survival. J Gastrointest Surg 2005;9:1191-204.
21. Motoi F, Rikiyama T, Katayose Y, et al. Retrospective evaluation of the influence of postoperative tumor marker status on survival and patterns of recurrence after surgery for pancreatic cancer based on RECIST guidelines. Ann Surg Oncol 2011;18: 371-9.
22. Toomey P, Hernandez J, Morton C, et al. Resection of portovenous structures to obtain microscopically negative margins during pancreaticoduodenectomy for pancreatic adenocarcinoma is worthwhile. Am Surg 2009;75:804-10.
23. Tseng JF, Raut CP, Lee JE. et al. Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 2004;8:935-49.
24. Siriwardana H, Siriwardena A. Systematic review of outcome of synchronous portal-superior mesenteric vein resection during pancreatectomy for cancer. Br J Surg 2006;93: 662-73.
25. Fukuda S, Oussoultzoglou E, Bachellier P. Significance of the depth of portal vein wall invasion after curative resection for pancreatic adenocarcinoma. Arch Surg 2007;142:172-9.
26. Zhou GW, Wu WD, Xiao WD, et al. Pancreatectomy combined with superior mesenteric-portal vein resection: report of 32 cases. Hepatobiliary Pancreat Dis Int 2005;4:130-4.
27. Shimada K, Sano T, Sakamoto Y, et al. Clinical implications of combined portal vein resection as a palliative procedure in patients undergoing pancreaticoduodenectomy for pancreatic head carcinoma. Ann Surg Oncol 2006;13:1569-78.
28. Verbeke CS, Gladhaug IP. Resection margin involvement and tumour origin in pancreatic head cancer. Br J Surg 2012;199: 1036-49.
29. Esposito I, Kleeff J, Bergmann F, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 2008;15: 1651-60.
30. Verbeke CS, Knapp J, Gladhaug IP. Tumour growth is more dispersed in pancreatic head cancers than in rectal cancer: implications for resection margin assessment. Histopathology 2011;59: 1111-21.